Effect of Astragalus Membranaceus for Troponin I and Myocardial Enzymes During Ischemia Reperfusion Injury in Valve Replacement with Cardiopulmonary Bypass

YUAN Gui-xiu,CHANG Ye-tian,ZOU Ding-quan,XU Jun-mei,LI Li,CHEN Ai-wu
DOI: https://doi.org/10.3969/j.issn.1009-2188.2007.01.019
2007-01-01
Abstract:Objective To investigate the cardioprotection effect of astragalus membranaceus during myocardial ischemia reperfusion injury(MIRI)in valve replacement with cardiopulmonary bypass(CPB).Methods Twenty-four rheumatic heart disease cases with NYHAFC Ⅱ~Ⅲ underwent selective valve replacement were randomized into astragaluse membranaceus group(group A) and control group,with 12 for each.Astragalus membranacues(0.6 g/kg) was diluted to 60 ml with 0.9 % NS and continuously intravenous infused in group A,whereas simplex 0.9% NS 60 ml was infused in control group.Creatine kinase(CK),creactine kinase-MB(CK-MB),and cardiac troponin I(CTnI) were measured at 15 minutes after anesthesia induction(T_0),before aortic crossclamp(T_1),20 minutes after aortic clamping(T_2),30 minutes(T_3) and 2 hours(T_4) after aortic reopening,and 24 hours after operation(T_5).Results(1)The concentration of CK,CK-MB and CTnI at T_0 was normal,and there was no significant difference between two groups(P0.05).(2) The serum levels of CK,CK-MB and CTnI ascend in both groups at T_2~T_5 time points: CK of T_4 and T_5,CK-MB at T_3,T_4 and T_5 were obviously higher than those of T_0 respectively(P0.05),furthermore there was statistic difference of CK at T_2 between two groups(P0.05).CTnI was significant rising at T_3,T_4,T_5 than that of T_0 in two groups(P0.05).Compare with control group,CTnI was remarkably lower in group A(P0.05).Conclusion Astragalus membranaceus could protect MIRI by reducing CtnI level in CPB.
What problem does this paper attempt to address?